Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)

NCT01020487 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease Stage 3 and 4

Interventions

DRUG: Paricalcitol
DRUG: Placebo

Sponsor

AbbVie (prior sponsor, Abbott)